CTOs on the Move

Imperative

www.imperative.com

 
Imperative is the enterprise peer coaching platform that combines AI technology and behavioral science to manage, scale, and measure peer coaching programs that address the needs for social connection and learning in the new world of work. Imperative is powered by its employee purpose profiling technology that enables the platform to accelerate trust between employees and enable everyone to serve as a coach for each other - reducing voluntary turnover by 35%. Since its launch in 2020, large and quickly growing companies like Microsoft, Hasbro, Accolade, GSK, Boston Scientific, Airbnb, and Zillow have adopted the platform to break down barriers ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imperative.com
  • 1201 Second Avenue Suite 917
    Seattle, WA USA 98101
  • Phone: 530.260.1502

Executives

Name Title Contact Details
J.R. Jesson
Chief Technology Officer Profile

Similar Companies

Taltopia.Com

Taltopia.Com is a North Hollywood, CA-based company in the Software and Internet sector.

3Plus1 Technology

3Plus1 Technology is a Saratoga, CA-based company in the Software and Internet sector.

Quia Corporation

Quia Corporation is a San Mateo, CA-based company in the Software and Internet sector.

Simplion Technologies Inc

Simplion Technologies Inc is a Milpitas, CA-based company in the Software and Internet sector.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.